Ocugen, Inc. (NASDAQ:OCGN) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.
Ocugen, Inc.'s stock currently trades at $1.49 with a market capitalization of $409.1M. The Healthcare company's stock moved following the disclosure.


